The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021
US$ 1,190.00
... from 7 viewpoints: 1. Renal Cell Carcinoma (RCC) - Disease Overview 2. Renal Cell Carcinoma (RCC) - Epidemiology 3. Global Renal Cell Carcinoma - Diagnosed Incident Cases to 2023 (8 Countries Covered) 4. Global Renal Cell Carcinoma - Five-Year Diagnosed ... (11 Brands Covered) 6. Global Renal Cell Carcinoma Drugs - Pipeline Analysis (18 Drugs Covered) 7. Global Renal Cell Carcinoma Drugs – Market Drivers and Restraints Global Renal Cell Carcinoma - Diagnosed Incident Cases ...
May 2016
148 pages
Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)
US$ 800.00
... “Global Injectable Drug Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global injectable market with detailed analysis of the actual and the expected market size along ... . The competition in the global injectable drug market is stiff and dominated by the big players like Pfizer, Inc. Further, key players of the injectable drug market such as Merck ...
May 2016
57 pages
Orphan Drug Commercial Models: Sustaining the rare disease business
US$ 695.00
... a part, so which model is best and what are the considerations which underpin that choice? This report analyses current orphan drug commercial models, assesses their ... for orphan drugs commercial teams to ensure that their business model works for all stakeholders? Key components: What are the key components of current commercial models ...
May 2016
-
Japan Generics Drug Market Outlook 2020
US$ 1,500.00
... Japan Generics Drug Market Outlook 2020” Report Highlights: Introduction to Japanese Generic Drug Market Attractiveness of Japanese Generic Market Super Generics in Japan Japan Healthcare System & Generic Drugs Different Parameters for Generic & Branded Drugs Comparison of Generic Drugs in US & Japan Japan ...
April 2016
66 pages
Pay-for-Performance and Drug Pricing: Impact and Response of Pharma [2016]
US$ 695.00
... , what can Pharma do to ensure positive payer support for its pricing proposals? Pay-for-Performance and Drug Pricing Pressure: Impact and Response from Pharma intensively examines the ... setting the pay-for-performance vs pricing status quo agenda Understand how public payers are reforming health delivery and assess the likely impact on pharma ...
March 2016
-
Investigation Report on China Fluoxetine Market, 2010-2019
US$ 2,000.00
... first in Belgium in 1986. Fluoxetine is a kind of selective serotonin reuptake inhibitors (SSRI) antidepressants and its medicinal form is Fluoxetine hydrochloride. Eli Lilly and ... number of Fluoxetine drugs on the market. There is a broad demand market of Fluoxetine in China. From 2010 to 2014, according to CRI’s survey on sample hospitals, CAGR of Fluoxetine is up to 9.68%. Eli ...
February 2016
20 pages
Investigation Report on China Methylcobalamin Market, 2010-2019
US$ 2,000.00
... more information: Market scale of Methylcobalamin in China Market Competitive pattern of Methylcobalamin in China Sales price of Methylcobalamin made by different enterprises in China Market outlook of Methylcobalamin in China The author recommends the following people to purchase this report: Production enterprises of methylcobalamin ...
February 2016
20 pages
US Generic Drug Market Opportunity Outlook 2020
US$ 1,500.00
... Generic Drugs Supportive Features of US Generic Drug Laws Effect of Generic Drug Import on US Economy Methods to Achieve Higher Cost Arbitrage by Generic Drugs Role of Online Pharmacies in Expansion of US Generic Drugs Market US Generic Drugs Market ...
February 2016
100 pages
Global Renal Cell Carcinoma Drugs Market 2020
US$ 1,500.00
... more drugs in various phases of clinical trials, which will help in the growth of this market. According to the report “Global Renal Cell Carcinoma Drugs Market 2020”, the renal cell carcinoma drugs market is anticipated to cross US$ 4 Billion by 2020. The report provides a detailed analysis of the market for these drugs. The ...
February 2016
65 pages
Innovations in Drug Pricing and Reimbursement (2016)
US$ 2,195.00
... friends when it comes to drug pricing. Public, health professional, political and payer hostility is growing worldwide as the prices of new drugs for chronic disease, specialty ... of justifying high drug prices to fund innovation and development need an overhaul? Risk Sharing: Are risk-sharing, value-based pricing and pricing by indication the best ...
February 2016
-
Global Orphan Drugs Market Report: 2016 Edition
US$ 800.00
... to Solid Tumors, attractive pricing option for orphan drug competitors and striking opportunities in developing orphan drugs. The report, “Global Orphan Drugs Market” analyzes the current prevailing condition of the ...
January 2016
56 pages
Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020
US$ 3,390.00
... ). Human insulin drugs segment is expected to account for the larger share of the global human insulin market in 2015, followed by insulin delivery devices. Significant demand growth for human insulin drugs during ... : Market Penetration: Comprehensive information on the human insulin products offered by the top 10 players in the global market. The report analyzes the human insulin market by product, drug type, drug brand ...
January 2016
92 pages
Global Markets for Drug Repurposing
US$ 5,500.00
The global market for drug repurposing will grow from nearly ... period of 2015-2020. The U.S. dominated the drug repurposing market and should reach approximately $13.7 in 2015 and close ... billion by 2020, rising at a CAGR of 5.4%. The non-U.S. market is expected to increase from $ 10.6 billion in 2015 to nearly ...
January 2016
103 pages
Global Orphan Drugs Market Outlook 2020
US$ 1,500.00
... boost for the companies developing orphan drugs all over the world. According to the report “Global Orphan Drugs Market Outlook 2020”, the orphan drug market is anticipated to reach around US$ 180 Billion by 2020. The report provides a detailed analysis of the market for these orphan drugs. An estimation of the market ...
January 2016
70 pages
Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)
US$ 2,000.00
... research report, “Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: 65 years, 65 years; By Region; Global Dementia Market)”, global Alzheimer’s market is projected ...
December 2015
106 pages
India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution)
US$ 2,200.00
... , Sanofi & Abbott whereas companies in devices market in India include RMS India, Nihon Kohden etc. Scope of the Report India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and ...
December 2015
114 pages
Preventive Asthma Drug Market Outlook 2020
US$ 1,500.00
... , and others. The drugs by these players contributed millions of dollars to their revenue in 2014. In its latest research, “Preventive Asthma Drug Market Outlook 2020”, RNCOS presents a comprehensive ... 2020. The market was estimated at US$ 22 Billion in 2014. Our analysts have segmented the preventive asthma drug industry depending on the type of drugs and geographical distribution ...
December 2015
45 pages
Global Vitamin D3 Market Outlook 2016-2021
US$ 2,800.00
... liver, cholecalciferol (vitamin D3) is converted to calcidiol, which is also known as calcifediol (INN), 25-hydroxycholecalciferol (aka 25-hydroxyvitamin D3 — abbreviated 25(OH) D3). GCC's report, Global Vitamin D3 Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Vitamin D3 market collected from ...
December 2015
110 pages
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis
US$ 2,519.00
... same number of ADC programs are in preclinical R&D. Download Samples Pages: Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis For the first ... entitled „Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis“ is based on the analysis of more than 90 companies, more than 100 ADC drug profiles ...
November 2015
470 pages
2016 Europe Drugs of Abuse Testing Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK
US$ 5,200.00
... -page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... , Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will ...
November 2015
300 pages
2016 Global Drugs of Abuse Testing Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts ... Opiates Phencyclidine (PCP) Propoxphene During the next decade, the abused drug testing market will undergo significant transformation. These changes will ...
November 2015
318 pages
2016 Global Therapeutic Drug Monitoring (TDM) Market: Test Volume and Sales Country Segment Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US
US$ 6,800.00
... from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts ...
November 2015
313 pages
2016 Future Horizons and Growth Strategies in the European Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 5,200.00
Complete report $6,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500. This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, ...
November 2015
300 pages
2016 Future Horizons and Growth Strategies in the European Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 5,200.00
This new 291-page report from VPGMarketResearch provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
291 pages
2016 Future Horizons and Growth Strategies in the French Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 260-page report from VPGMarketResearch provides a comprehensive analysis of the French drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
260 pages
2016 Future Horizons and Growth Strategies in the French Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
247 pages
2016 Future Horizons and Growth Strategies in the German Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 262-page report from VPGMarketResearch provides a comprehensive analysis of the German drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
262 pages
2016 Future Horizons and Growth Strategies in the German Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 249-page report from VPGMarketResearch provides a comprehensive analysis of the German therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
249 pages
2016 Future Horizons and Growth Strategies in the Global Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 6,800.00
Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500. This new 318-page report from VPGMarketResearch contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, ...
November 2015
318 pages
2016 Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 6,800.00
Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500. This new 313-page report from VPGMarketResearch contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts ...
November 2015
313 pages
2016 Future Horizons and Growth Strategies in the Italian Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 260-page report from VPGMarketResearch provides a comprehensive analysis of the Italian drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
260 pages
2016 Future Horizons and Growth Strategies in the Italian Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the Italian therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
247 pages
2016 Future Horizons and Growth Strategies in the Japanese Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 2,200.00
This new 260-page report from VPGMarketResearch provides a comprehensive analysis of the Japanese drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
260 pages
2016 Future Horizons and Growth Strategies in the Japanese Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 2,200.00
This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
247 pages
2016 Future Horizons and Growth Strategies in the Spanish Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 260-page report from VPGMarketResearch provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
260 pages
2016 Future Horizons and Growth Strategies in the Spanish Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 249-page report from VPGMarketResearch provides a comprehensive analysis of the Spanish therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
249 pages
2016 Future Horizons and Growth Strategies in the UK Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 260-page report from VPGMarketResearch provides a comprehensive analysis of the UK drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts ...
November 2015
260 pages
2016 Future Horizons and Growth Strategies in the UK Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 1,960.00
This new 247-page report from VPGMarketResearch provides a comprehensive analysis of the UK therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
247 pages
2016 Future Horizons and Growth Strategies in the US Drugs of Abuse Testing Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 2,800.00
This new 262-page report from VPGMarketResearch provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts ...
November 2015
262 pages
2016 Future Horizons and Growth Strategies in the US Therapeutic Drug Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 2,800.00
This new 249-page report from VPGMarketResearch provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales ...
November 2015
249 pages
Drug Delivery - Innovations, trends, and their impact on pharma
US$ 2,100.00
... need Drug Delivery - Innovations, trends, and their impact on pharma Revolutionary changes are disrupting the status quo simply through developments in the way drugs are ... on innovation in the drug delivery market, reimbursement concerns and access issues Who needs this report? Presidents and VPs of product development – to see the drugs ...
November 2015
-
